Tyra Biosciences (TYRA) Shares Outstanding (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Shares Outstanding (Entity) came in at $59.5 million in Q1 2026, up 12.02% YoY from $53.1 million in Q1 2025, and up 10.73% on a QoQ basis from $53.7 million in Q4 2025.
Tyra Biosciences (TYRA) Shares Outstanding (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Shares Outstanding (Entity) data on file, last reported at $59.5 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 12.02% year-over-year to $59.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.5 million (up 12.02% YoY) and the FY2025 annual result came in at $53.7 million, up 5.83% from the prior year.
- Shares Outstanding (Entity) climbed to $59.5 million in Q1 2026, from $53.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $59.5 million in Q1 2026 to a low of $41.7 million in Q1 2022.
- A 5-year average of $48.3 million and a median of $50.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 1792.87% — and 2025, when it grew 0.84%.
- Tracing TYRA's Shares Outstanding (Entity) over 5 years: stood at $42.4 million in 2022, then advanced by 1.58% to $43.0 million in 2023, then climbed by 17.96% to $50.7 million in 2024, then gained by 5.83% to $53.7 million in 2025, then advanced by 10.73% to $59.5 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $59.5 million (Q1 2026), $53.7 million (Q4 2025), and $53.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | 65.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.75 Mn |
| Mar 31, 2026 | 61.75 Mn |
| Dec 31, 2025 | 59.60 Mn |
| Sep 30, 2025 | 59.67 Mn |
| Jun 30, 2025 | 59.55 Mn |
| Mar 31, 2025 | 59.34 Mn |
| Dec 31, 2024 | 57.22 Mn |
| Sep 30, 2024 | 58.87 Mn |
| Jun 30, 2024 | 58.67 Mn |
| Mar 31, 2024 | 52.23 Mn |
| Dec 31, 2023 | 42.70 Mn |
| Sep 30, 2023 | 42.87 Mn |
| Jun 30, 2023 | 42.59 Mn |
| Mar 31, 2023 | 42.39 Mn |
| Dec 31, 2022 | 41.88 Mn |
| Sep 30, 2022 | 42.00 Mn |
| Jun 30, 2022 | 41.78 Mn |
| Mar 31, 2022 | 41.55 Mn |
| Dec 31, 2021 | 13.78 Mn |
| Sep 30, 2021 | 9.16 Mn |